Staphylococcus aureus cell wall synthesis enzymes

The cell wall of Staphylococcus aureus is a vital, rigid structure composed primarily of peptidoglycan, which provides mechanical strength and protects the bacterium from osmotic lysis. The synthesis of this cell wall is a complex, multi-stage process involving a suite of enzymes that operate in the cytoplasm, the cell membrane, and the extracellular space. Key enzymes include the Mur ligases (MurA-F), which synthesize the peptidoglycan precursors, and the Penicillin-Binding Proteins (PBPs), which catalyze the final cross-linking of the cell wall polymer. Because these enzymes are essential for bacterial survival and are absent in human cells, they serve as primary targets for many of the most effective classes of antibiotics. Drugs such as beta-lactams (e.g., penicillins and cephalosporins) directly inhibit PBPs, while others like fosfomycin and vancomycin target earlier stages or the substrate itself. However, the clinical utility of targeting these enzymes is constantly challenged by the emergence of resistance mechanisms, such as the production of alternative PBPs (e.g., PBP2a in MRSA) or changes in the peptidoglycan precursors.

Other names

Peptidoglycan biosynthesis enzymesS. aureus cell wall enzymesBacterial cell wall synthesis enzymesMur enzymesPenicillin-binding proteins

Inhibition of various stages of peptidoglycan synthesis, including precursor formation (Fosfomycin), lipid carrier recycling (Bacitracin), and cross-linking (Beta-lactams).